Form 4: Arteris VP & General Counsel Sells Shares

Arteris VP and General Counsel, Paul L. Alpern, executed a planned sale of company stock following option exercise in early 2026.

Summary

• Paul L. Alpern, VP and General Counsel of Arteris, Inc. (AIP), reported transactions involving company common stock.
• On January 5, 2026, Alpern acquired 2,500 shares of common stock through the exercise of options at a price of $9.28 per share.
• Immediately following the option exercise on January 5, 2026, Alpern sold 2,500 shares of common stock at a price of $16.00 per share.
• On January 6, 2026, an additional 4,318 shares of common stock were sold at a weighted average price of $16.8913 per share, with individual sales ranging from $15.86 to $17.62.
• All reported transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Alpern on June 5, 2025.
• Following these transactions, Alpern's direct beneficial ownership of Arteris common stock decreased from 64,468 shares to 57,650 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can sometimes be viewed negatively, the fact that it was executed under a pre-planned 10b5-1 trading plan mitigates concerns about reactive selling or a lack of confidence in the company's future. It represents a routine liquidity event for an executive.

Positives

• The transactions were executed under a pre-established Rule 10b5-1 trading plan, indicating a structured and non-discretionary approach to stock sales, which can mitigate concerns about reactive insider selling.
• The exercise of options demonstrates the officer realizing value from their compensation package.

Negatives

• The sale of 6,818 shares by a key executive, even if planned, reduces their direct equity stake in the company, which could be perceived as a slight reduction in alignment with shareholder interests.

Management Comments

• Transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 5, 2025.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even if planned, slightly dilutes the executive's direct alignment with shareholder interests, though the 10b5-1 plan provides transparency.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The Reporting Person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon request from the Issuer, security holders, or the SEC staff.

Key Dates

Keywords

Arteris, AIP, Form 4, Insider Transaction, Stock Sale, Option Exercise, Paul Alpern, 10b5-1 Plan, Corporate Governance